Direxion Daily Biotech Top 5 Bull 2X ETF TBXU
Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed
- Net expense ratio
- 0.97%
- Net assets
- $2.6M
- Holdings
- 10
- 12-month distribution yield
- 1.20%
- Asset class
- Derivatives-based
Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) is an exchange-traded fund listed on NYSE Arca in the United States, issued by Direxion. Its category is Derivatives-based. Its last price was US$37.91 on 20 Oct 2026. Its net expense ratio is 0.97% a year, from its prospectus dated 12 Jun 2025. It reported net assets of US$2.57 million as of 31 Jul 2026. Its latest holdings report lists 10 holdings as of 31 Jul 2026. Over the last 12 months it paid distributions of US$0.45 a unit, a 12-month distribution yield of 1.20%, paid quarterly.
Fees
- Total annual operating expenses (gross)
- 0.99%
- Net, after fee waivers or reimbursements
- 0.97%
- Management fee
- 0.75%
- Prospectus date
- 12 Jun 2025
- Filed with the SEC
- 8 Aug 2025
Size and reporting
- Net assets
- $2,568,167
- Total assets
- $2,577,083
- Holdings as of
- 31 Jul 2026
- Report made public
- 28 Sep 2026 (59 days after the month end)
Top holdings
Largest 10 of 10 positions, as of 31 Jul 2026. Weight is the percent of net assets the fund reported.
| # | Holding | Identifier | Weight | Value (USD) | Type | Country | Currency |
|---|---|---|---|---|---|---|---|
| 1 | GOLDMAN FINANCIAL GOLDMAN FINL SQ TRSRY INST 506 | No identifier reported | 29.36% | $754K | Short-term investment vehicles (cash funds) | United States | USD |
| 2 | DREYFUS DREYFUS GOV'T CASH MGMT -INSTITUTIONAL CUSIP 262006208 DGCXX (#289) | No identifier reported | 21.64% | $556K | Short-term investment vehicles (cash funds) | United States | USD |
| 3 | REGENERON PHARMACEUTICALS INC Regeneron Pharmaceuticals, Inc. COM USD0.001 | US75886F1075 | 9.09% | $233K | Equity (common) | United States | USD |
| 4 | AMGEN INC Amgen Inc. COM USD0.0001 | US0311621009 | 7.95% | $204K | Equity (common) | United States | USD |
| 5 | VERTEX PHARMACEUTICALS INC Vertex Pharmaceuticals Incorporated COM USD0.01 | US92532F1003 | 7.84% | $201K | Equity (common) | United States | USD |
| 6 | GILEAD SCIENCES INC Gilead Sciences, Inc. COM USD0.001 | US3755581036 | 7.58% | $195K | Equity (common) | United States | USD |
| 7 | ARGENX SE - ADR | US04016X1019 | 6.98% | $179K | Equity (common) | Netherlands | USD |
| 8 | GOLDMAN SACHS LIQ ES FD A GOLDMAN SACHS FIN GOV 465 INSTITUT | No identifier reported | 6.23% | $160K | Short-term investment vehicles (cash funds) | United States | USD |
| 9 | DX D BIOTECH T 5 BULL 2X ETF SWAP | No identifier reported | 2.83% | $73K | Other derivatives | United States | USD |
| 10 | DX D BIOTECH T 5 BULL 2X ETF SWAP | No identifier reported | 0.62% | $16K | Other derivatives | United States | USD |
Breakdowns
Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.
Warning: Uses derivatives
Asset type
| Type | Weight | Bar |
|---|---|---|
| Short-term investment vehicles (cash funds) | 57.24% | |
| Equity (common) | 39.44% | |
| Other derivatives | 3.45% |
Country
| Country | Weight | Bar |
|---|---|---|
| United States | 93.14% | |
| Netherlands | 6.98% |
Currency exposure
| Currency | Weight | Bar |
|---|---|---|
| US dollar (USD) | 100.12% |
Sector
| Sector | Weight | Bar |
|---|---|---|
| Health Care | 39.44% |
Source: SEC Form N-PORT (opens in a new tab) Holdings as of
Distributions
- Paid in the last 12 months
- $0.4530
- 12-month yield
- 1.20%
- Frequency
- Quarterly
- Latest ex-date
- 22 Sep 2026
12-month yield = distributions per unit with an ex-date in the last 12 months ($0.4530) ÷ latest price ($37.91) × 100 = 1.20%. It looks back, so it is not a forecast; special distributions in the window are included.
Why a distribution yield is not the fund's return: yield vs total return
Distribution history table (5 payments)
| Ex-date | Amount per unit |
|---|---|
| 22 Sep 2026 | $0.1420 |
| 23 Jun 2026 | $0.1110 |
| 24 Mar 2026 | $0.0990 |
| 23 Dec 2025 | $0.1010 |
| 10 Dec 2025 | $0.3110 |
Filings and sources
- Form N-PORT report for July 2026 (opens in a new tab)
- Prospectus filing with the fee table (opens in a new tab)
- All SEC filings for this fund series (S000092912) (opens in a new tab)
- Nasdaq Trader symbol directory (opens in a new tab)
- Yahoo Finance quote and distributions (opens in a new tab)
- How the ETF figures are collected
Compare with
Largest funds in the same category:
- TBXU and TQQQ ProShares UltraPro QQQ
- TBXU and SOXL Direxion Daily Semiconductor Bull 3X ETF
- TBXU and BBJP JPMorgan BetaBuilders Japan ETF
- TBXU and QLD ProShares Ultra QQQ